UPDATE
1-Glaxo, Theravance Breo lung drug fails to
extend life in
huge study
Sept 8 (Reuters) - GlaxoSmithKline Plc and its partner
Theravance Inc on Tuesday said their inhaled medicine
Breo failed to prolong
life of patients with chronic respiratory disease in a huge, high-stakes clinical trial.
